Debevoise & Plimpton advised SVB Leerink as co-financial advisor to LHC Group on the deal while Alston & Bird represented LHC Group. LHC Group (NASDAQ: LHCG)...
You must be a Standard 1 Year member to access this content.
Cooley advised AN2 Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering. AN2 Therapeutics, Inc. announced its upsized initial public offering of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Travere Therapeutics, Inc. executed its offering of US$275 million aggregate principal amount of 2.25% convertible senior notes due...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representative of the underwriters, SVB Securities LLC and Robert W. Baird & Co. Incorporated in the IPO. Walkers acted as Cayman Islands...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agents in the transaction. The transaction consists in a new SEC-registered at-the-market offering program by Denali Therapeutics Inc. under which Denali...
You must be a Standard 1 Year member to access this content.
White & Case has advised J.P. Morgan Securities LLC, SVB Leerink LLC, BofA Securities, Inc., Evercore Group L.L.C. and RBC Capital Markets, LLC as representatives of...
You must be a Standard 1 Year member to access this content.
Covington represented UCB, while Latham & Watkins represented Zogenix on the deal. Fried Frank acted as counsel to BofA Securities and SVB Leerink as financial advisors to...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal while Goodwin Procter represented Amylyx Pharmaceuticals. Amylyx Pharmaceuticals, Inc. (“Amylyx”), a clinical-stage pharmaceutical company...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the placement agents in the offering. Cryoport executed its direct offering of 3,072,038 shares of its common stock, for total gross proceeds of approximately $249.1...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the initial purchasers in the offering. Latham & Watkins represented Cryoport in the offering. Cryoport, Inc. executed the offering of $402.5 million aggregate...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the transaction. Minerva Surgical, Inc. (Minerva Surgical), a women’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB),...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for patients suffering...
You must be a Standard 1 Year member to access this content.
